中医辨证治疗支气管扩张的临床效果观察
|
摘要
目的:探究中医辨证治疗支气管扩张的临床疗效。方法:选取2017年1月-2018年1月来我院就诊的30例支气管扩张患者为受试对象。将其随机分为实验组15例,对照组15例。对照组受试对象以西医治疗,实验组受试对象以中药治疗。比较两组治疗效果。结果:实验组中显效8例,有效6例,无效1例,治疗有效率为93.33%,高于对照组的80.00%,差异具有统计学意义(P <0.05)。中药治疗的实验组治疗前后平均收缩压分别为(111.35±3.68)mm Hg,(109.81±4.06)mm Hg;舒张压分别为(79.82±2.17)mm Hg,(81.69±2.36)mm Hg;心率分别为(80.06±5.22)次/分、(77.32±6.38)次/分。治疗前后平均收缩压、舒张压及心率的差异均无统计学意义(P> 0.05)。结论:相比西医抗生素治疗,中医辨证治疗支气管扩张具有更高的临床治疗有效率,经药物安全性评价结果提示中医治疗安全性良好,值得推广。
Objective: To explore the clinical efficacy of TCM syndrome differentiation on bronchiectasis. Methods: 30 patients were randomly divided into the experimental group and the control group, 15 patients in each. The control group was given western medicine.The experimental group was given TCM medicine. The efficacy in two groups was compared. Results: 8 cases were marked in the experimental group; 6 cases were effective; 1 case was ineffective; and the efficiency was 93.33%, higher than 80.00% in the control group,with a statistically significant difference(P<0.05). The average systolic pressure before and after treatment in the experimental group was(111.35±3.68) mm Hg and(109.81±4.06) mm Hg respectively; diastolic pressure was(79.82±2.17) mm Hg and(81.69±2.36) mm Hg respectively; and heart rate was(80.06±5.22) times/minutes and(77.32±6.38) times/minutes respectively. There was no significant difference in average systolic pressure, diastolic pressure and heart rate between before and after treatment(P>0.05). Conclusion: TCM syndrome differentiation shows a higher clinical efficiency, is safety, and worth popularizing.
Objective: To explore the clinical efficacy of TCM syndrome differentiation on bronchiectasis. Methods: 30 patients were randomly divided into the experimental group and the control group, 15 patients in each. The control group was given western medicine.The experimental group was given TCM medicine. The efficacy in two groups was compared. Results: 8 cases were marked in the experimental group; 6 cases were effective; 1 case was ineffective; and the efficiency was 93.33%, higher than 80.00% in the control group,with a statistically significant difference(P<0.05). The average systolic pressure before and after treatment in the experimental group was(111.35±3.68) mm Hg and(109.81±4.06) mm Hg respectively; diastolic pressure was(79.82±2.17) mm Hg and(81.69±2.36) mm Hg respectively; and heart rate was(80.06±5.22) times/minutes and(77.32±6.38) times/minutes respectively. There was no significant difference in average systolic pressure, diastolic pressure and heart rate between before and after treatment(P>0.05). Conclusion: TCM syndrome differentiation shows a higher clinical efficiency, is safety, and worth popularizing.
引文
[1]黄钦蓉,凌刘,何兴,等.支气管扩张患者中致病菌感染与肺功能相关性分析[J].重庆医学,2017,46(11):1535-1537.
[2]Navaratnam,V.,Millett,E.R.C.,Hurst,J.R.,et al.Bronchiectasis and the risk of cardiovascular disease:a population-based study[J].Thorax2017,72(2):161-166.
[3]贺立山,翁孝刚.内科学[M].7版.西安:第四军医大学出版社,2008.
[4]符丽.支气管扩张中医证素分布规律及证候分型特点分析[J].广州中医药大学学报,2016,33(3):310-313.
[5]谢冰,张利君.中西医结合护理用于支气管扩张咯血患者中的临床效果[J].家庭医药,2016,15(8):178.
[6]李文,连乐燊,蒋紫云.清热化痰法配合低剂量激素治疗AECOPD临床观察[J].深圳中西医结合杂志,2016,26(17):23-24.
[7]Chalmers,J.D.,Polverino,E..Macrolides,mucoactive drugs and adherence for the management of bronchiectasis[J].European Respiratory Journal,2018,51(1):1702033.
[8]Gao,Y.H.,Guan,W.J.,Zhu,Y.N.,et al.Antibiotic-resistant pseudomonas aeruginosa infection in patients with bronchiectasis:prevalence,risk factors and prognostic implications[J].International Journal of Chronic Obstructive Pulmonary Disease,2018,13:237-246.
[2]Navaratnam,V.,Millett,E.R.C.,Hurst,J.R.,et al.Bronchiectasis and the risk of cardiovascular disease:a population-based study[J].Thorax2017,72(2):161-166.
[3]贺立山,翁孝刚.内科学[M].7版.西安:第四军医大学出版社,2008.
[4]符丽.支气管扩张中医证素分布规律及证候分型特点分析[J].广州中医药大学学报,2016,33(3):310-313.
[5]谢冰,张利君.中西医结合护理用于支气管扩张咯血患者中的临床效果[J].家庭医药,2016,15(8):178.
[6]李文,连乐燊,蒋紫云.清热化痰法配合低剂量激素治疗AECOPD临床观察[J].深圳中西医结合杂志,2016,26(17):23-24.
[7]Chalmers,J.D.,Polverino,E..Macrolides,mucoactive drugs and adherence for the management of bronchiectasis[J].European Respiratory Journal,2018,51(1):1702033.
[8]Gao,Y.H.,Guan,W.J.,Zhu,Y.N.,et al.Antibiotic-resistant pseudomonas aeruginosa infection in patients with bronchiectasis:prevalence,risk factors and prognostic implications[J].International Journal of Chronic Obstructive Pulmonary Disease,2018,13:237-246.